Stable extended release oral dosage composition comprising lorat

Details Stable extended release oral dosage composition comprising lorat Stable extended release oral dosage composition comprising lorat

1992-10-23

1994-05-24

Michl, Paul R.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424463, 424465, 424468, 424469, 424470, 424474, 424475, 514849, 514853, 514964, 514965, A61K 936

Patent

active

053146972

ABSTRACT:
A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.

REFERENCES:
patent: 4282233 (1981-08-01), Vilani
patent: 4990535 (1991-02-01), Cho et al.
patent: 5100675 (1992-03-01), Cho et al.
Package Label for Claritin.RTM. (Loratadine, 5 mg, pseudoephedrine sulfate, 120 mg) Extra Repetabs Schering, Canada.

Affiliated with

Also associated with

Rating

Stable extended release oral dosage composition comprising lorat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable extended release oral dosage composition comprising lorat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable extended release oral dosage composition comprising lorat will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1971367